formin binding protein 1 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored FNBP1P1 profile across patient tissues and cancer cell-line models. FNBP1P1 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, FNBP1P1 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, FNBP1P1 RNA expression shows 20,030 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UCS, HNSC, and THYM as cancer lineages where FNBP1P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for FNBP1P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes FNBP1P1 survival associations across molecular data types. FNBP1P1 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible FNBP1P1 RNA expression–survival associations across cancer types. High FNBP1P1 expression shows unfavorable associations in COAD, ACC and UVM, but favorable associations in UCS, READ and BRCA. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for FNBP1P1 RNA expression.
This table summarizes FNBP1P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for FNBP1P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. FNBP1P1 shows lower tumor expression in THCA and KICH and higher tumor expression in HNSC, LUSC, COAD and LIHC. The HNSC box plot shows higher FNBP1P1 RNA expression in tumor versus normal tissue (log2 FC = +0.749, t-test p < 0.001).
This table shows molecular features associated with FNBP1P1 in patient tissues and cancer cell lines. In patient samples, FNBP1P1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
